Top compounds associated with response to FSHR


Feature Type Standardized
Nominal ANOVA
mRNA dabrafenib CTRPv2 pan-cancer AAC -0.058 0.2
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC 0.045 0.2
mRNA Bortezomib GDSC1000 pan-cancer AAC 0.061 0.2
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.2
mRNA ZSTK474 GDSC1000 pan-cancer AAC 0.037 0.2
mRNA VAF-347 CTRPv2 pan-cancer AAC -0.056 0.2
mRNA sitagliptin CTRPv2 pan-cancer AAC -0.091 0.2
mRNA Cytarabine CTRPv2 pan-cancer AAC -0.034 0.2
mRNA avicin D CTRPv2 pan-cancer AAC -0.065 0.2
mRNA BRD-K75293299 CTRPv2 pan-cancer AAC -0.087 0.2
Download CSV